Biotechnology Innovation Organization analyst David Thomas says it's too soon to tell if the downturn in 2016 has permeated all areas of the biotech industry, but the analyst notes how "shocked" he was by the strength of the industry over the last year and where that funding was going.
Just three weeks ahead of its annual BIO conference in San Diego, the industry group released a report discussing financing...







